Edwin M. Spithoven

925 total citations
19 papers, 289 citations indexed

About

Edwin M. Spithoven is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Edwin M. Spithoven has authored 19 papers receiving a total of 289 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in Edwin M. Spithoven's work include Genetic and Kidney Cyst Diseases (13 papers), Cystic Fibrosis Research Advances (4 papers) and Renal and related cancers (3 papers). Edwin M. Spithoven is often cited by papers focused on Genetic and Kidney Cyst Diseases (13 papers), Cystic Fibrosis Research Advances (4 papers) and Renal and related cancers (3 papers). Edwin M. Spithoven collaborates with scholars based in Netherlands, United States and Germany. Edwin M. Spithoven's co-authors include Esther Meijer, Ron T. Gansevoort, Niek F. Casteleijn, Dorien J.M. Peters, Wendy E. Boertien, Jack F.M. Wetzels, Joost P.H. Drenth, Darius Soonawala, Mahdi Salih and Folkert W. Visser and has published in prestigious journals such as Kidney International, American Journal of Kidney Diseases and Nephrology Dialysis Transplantation.

In The Last Decade

Edwin M. Spithoven

18 papers receiving 282 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edwin M. Spithoven Netherlands 9 227 126 95 64 63 19 289
A. Lianne Messchendorp Netherlands 10 128 0.6× 84 0.7× 85 0.9× 36 0.6× 34 0.5× 25 285
Bjarne Ørskov Denmark 6 219 1.0× 136 1.1× 103 1.1× 46 0.7× 76 1.2× 8 281
Juan Alberto Piñero‐Fernández Spain 7 125 0.6× 132 1.0× 102 1.1× 17 0.3× 36 0.6× 13 271
David Fasel United States 7 111 0.5× 124 1.0× 73 0.8× 14 0.2× 62 1.0× 8 228
Yasufumi Ohtsuka Japan 9 68 0.3× 78 0.6× 99 1.0× 26 0.4× 53 0.8× 20 228
C. Steinkamm Germany 5 280 1.2× 225 1.8× 31 0.3× 56 0.9× 68 1.1× 11 322
Jonathan Z. Luo United States 5 121 0.5× 99 0.8× 25 0.3× 21 0.3× 14 0.2× 7 190
Shivaram Hegde United Kingdom 6 27 0.1× 96 0.8× 110 1.2× 26 0.4× 45 0.7× 11 216
Eduardo Machuca Chile 8 57 0.3× 180 1.4× 341 3.6× 81 1.3× 12 0.2× 10 401
Kah Mean Thong Malaysia 6 79 0.3× 61 0.5× 49 0.5× 14 0.2× 22 0.3× 12 152

Countries citing papers authored by Edwin M. Spithoven

Since Specialization
Citations

This map shows the geographic impact of Edwin M. Spithoven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edwin M. Spithoven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edwin M. Spithoven more than expected).

Fields of papers citing papers by Edwin M. Spithoven

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edwin M. Spithoven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edwin M. Spithoven. The network helps show where Edwin M. Spithoven may publish in the future.

Co-authorship network of co-authors of Edwin M. Spithoven

This figure shows the co-authorship network connecting the top 25 collaborators of Edwin M. Spithoven. A scholar is included among the top collaborators of Edwin M. Spithoven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edwin M. Spithoven. Edwin M. Spithoven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Vries, Aiko P. J. de, Maarten E. Tushuizen, Danny van der Helm, et al.. (2025). A Retrospective Test-Negative Case-Control Study to Evaluate Influenza Vaccine Effectiveness in Preventing Influenza Among Immunocompromised Adults With a Solid Organ Transplant. Transplant International. 38. 14187–14187.
2.
Spithoven, Edwin M. & Alferso C Abrahams. (2021). Unilateral Pleural Effusion in a Hemodialysis Patient. Kidney360. 2(9). 1542–1543. 1 indexed citations
3.
Spithoven, Edwin M., Anke H. W. Bruns, P. J. A. Haas, et al.. (2020). Renal transplant patient survives a donor-derived abdominal invasive mucormycosis (Lichtheimia ramosa). Medical Mycology Case Reports. 30. 39–42. 4 indexed citations
4.
Messchendorp, A. Lianne, Edwin M. Spithoven, Esther Meijer, et al.. (2019). Effect of a Somatostatin Analogue on the Vasopressin Pathway in Patients With ADPKD. Kidney International Reports. 4(8). 1170–1174. 3 indexed citations
5.
Messchendorp, A. Lianne, Edwin M. Spithoven, Niek F. Casteleijn, et al.. (2018). Association of plasma somatostatin with disease severity and progression in patients with autosomal dominant polycystic kidney disease. BMC Nephrology. 19(1). 368–368. 8 indexed citations
6.
Lantinga, Marten A., Ruud G.L. de Sévaux, Tom J.G. Gevers, et al.. (2018). Clinical predictors of escalating care in hepatic and renal cyst infection in autosomal dominant polycystic kidney and liver disease.. PubMed. 76(5). 226–234. 6 indexed citations
7.
D‘Agnolo, Hedwig M. A., Niek F. Casteleijn, Tom J.G. Gevers, et al.. (2017). The Association of Combined Total Kidney and Liver Volume with Pain and Gastrointestinal Symptoms in Patients with Later Stage Autosomal Dominant Polycystic Kidney Disease. American Journal of Nephrology. 46(3). 239–248. 12 indexed citations
8.
Messchendorp, A. Lianne, Esther Meijer, Wendy E. Boertien, et al.. (2017). Urinary Biomarkers to Identify Autosomal Dominant Polycystic Kidney Disease Patients With a High Likelihood of Disease Progression. Kidney International Reports. 3(2). 291–301. 33 indexed citations
9.
Lantinga, Marten A., Hedwig M. A. D‘Agnolo, Niek F. Casteleijn, et al.. (2016). Hepatic Cyst Infection During Use of the Somatostatin Analog Lanreotide in Autosomal Dominant Polycystic Kidney Disease: An Interim Analysis of the Randomized Open-Label Multicenter DIPAK-1 Study. Drug Safety. 40(2). 153–167. 15 indexed citations
10.
D‘Agnolo, Hedwig M. A., Niek F. Casteleijn, Johan W. de Fijter, et al.. (2016). SP018THE ASSOCIATION OF COMBINED TOTAL KIDNEY AND LIVER VOLUME WITH GASTROINTESTINAL SYMPTOMS AND PAIN IN PATIENTS WITH LATER STAGE ADPKD. Nephrology Dialysis Transplantation. 31(suppl_1). i92–i92. 1 indexed citations
11.
Casteleijn, Niek F., Debbie Zittema, Stephan J. L. Bakker, et al.. (2015). Urine and Plasma Osmolality in Patients with Autosomal Dominant Polycystic Kidney Disease: Reliable Indicators of Vasopressin Activity and Disease Prognosis?. American Journal of Nephrology. 41(3). 248–256. 14 indexed citations
12.
Spithoven, Edwin M., Esther Meijer, Wendy E. Boertien, et al.. (2015). Feasibility of measuring renal blood flow by phase-contrast magnetic resonance imaging in patients with autosomal dominant polycystic kidney disease. European Radiology. 26(3). 683–692. 5 indexed citations
13.
14.
Casteleijn, Niek F., Edwin M. Spithoven, Maarten B. Rookmaaker, Mervyn D. I. Vergouwen, & Ron T. Gansevoort. (2014). Bilateral cysts in the choroid plexus in a patient with autosomal dominant polycystic kidney disease. Nephrology Dialysis Transplantation. 30(5). 859–860. 2 indexed citations
15.
Spithoven, Edwin M., Niek F. Casteleijn, P. Berger, & Roel Goldschmeding. (2014). Nephrectomy in Autosomal Dominant Polycystic Kidney Disease: A Patient with Exceptionally Large, Still Functioning Kidneys. Case Reports in Nephrology and Dialysis. 4(2). 109–112. 18 indexed citations
16.
Meijer, Esther, Joost P.H. Drenth, Hedwig M. A. D‘Agnolo, et al.. (2013). Rationale and Design of the DIPAK 1 Study: A Randomized Controlled Clinical Trial Assessing the Efficacy of Lanreotide to Halt Disease Progression in Autosomal Dominant Polycystic Kidney Disease. American Journal of Kidney Diseases. 63(3). 446–455. 54 indexed citations
17.
Spithoven, Edwin M., Esther Meijer, Wendy E. Boertien, et al.. (2013). Tubular Secretion of Creatinine in Autosomal Dominant Polycystic Kidney Disease: Consequences for Cross-sectional and Longitudinal Performance of Kidney Function Estimating Equations. American Journal of Kidney Diseases. 62(3). 531–540. 19 indexed citations
18.
Spithoven, Edwin M., Stephan J. L. Bakker, Jenny E. Kootstra‐Ros, Paul E. de Jong, & R. T. Gansevoort. (2013). Stability of creatinine and cystatin C in whole blood. Clinical Biochemistry. 46(15). 1611–1614. 10 indexed citations
19.
Smit, Andries J., et al.. (2012). Cardiovascular screening in general practice in a low SES area. BMC Family Practice. 13(1). 117–117. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Lianne Messchendorp Breakdown of academic impact, for papers by Bjarne Ørskov Breakdown of academic impact, for papers by Juan Alberto Piñero‐Fernández Breakdown of academic impact, for papers by David Fasel Breakdown of academic impact, for papers by Yasufumi Ohtsuka Breakdown of academic impact, for papers by C. Steinkamm Breakdown of academic impact, for papers by Jonathan Z. Luo Breakdown of academic impact, for papers by Shivaram Hegde Breakdown of academic impact, for papers by Eduardo Machuca Breakdown of academic impact, for papers by Kah Mean Thong
Rankless by CCL
2026